Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Page 1
Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease.
de Jong CMM, de Wit K, Black SA, Gwozdz AM, Masias C, Parks AL, Robert-Ebadi H, Talerico R, Woller SC, Klok FA. de Jong CMM, et al. Among authors: woller sc. J Thromb Haemost. 2023 Oct;21(10):2953-2962. doi: 10.1016/j.jtha.2023.06.023. Epub 2023 Jun 30. J Thromb Haemost. 2023. PMID: 37394119 Free article.
After pulmonary embolism or deep vein thrombosis, patients may face a broad spectrum of complications and long-term sequelae beyond the usual quality-of-care indicators of recurrent venous thromboembolism (VTE), bleeding complications, and survival. ...
After pulmonary embolism or deep vein thrombosis, patients may face a broad spectrum of complications and long-term sequelae beyond t …
Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non-valvular atrial fibrillation (cognitive decline and dementia in patients with non-valvular atrial fibrillation [CAF] trial).
Bunch TJ, May H, Cutler M, Woller SC, Jacobs V, Stevens SM, Carlquist J, Knowlton KU, Muhlestein JB, Steinberg BA, Anderson JL. Bunch TJ, et al. Among authors: woller sc. J Arrhythm. 2022 Sep 19;38(6):997-1008. doi: 10.1002/joa3.12781. eCollection 2022 Dec. J Arrhythm. 2022. PMID: 36524040 Free PMC article.
BACKGROUND: Atrial fibrillation (AF) is associated with a risk for cognitive impairment and dementia, which is more pronounced in patients with a history of clinical stroke. Anticoagulation use and efficacy impact long-term risk of dementia in AF patients in observational …
BACKGROUND: Atrial fibrillation (AF) is associated with a risk for cognitive impairment and dementia, which is more pronounced in patients w …
Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease.
den Exter PL, Woller SC, Robert-Ebadi H, Masias C, Morange PE, Castelli D, Hansen JB, Geersing GJ, Siegal DM, de Wit K, Klok FA. den Exter PL, et al. Among authors: woller sc. J Thromb Haemost. 2022 Aug;20(8):1910-1919. doi: 10.1111/jth.15776. Epub 2022 Jun 23. J Thromb Haemost. 2022. PMID: 35735219 Free PMC article.
Identification of patients at high risk of bleeding, and mitigating this risk, is an essential component of the immediate and long-term therapeutic management of VTE. The bleeding risk can be estimated by either implicit judgment, weighing individual predictors (clinical v …
Identification of patients at high risk of bleeding, and mitigating this risk, is an essential component of the immediate and long-term …
Depression as a Driving Force for Low Time in Therapeutic Range and Dementia in Patients With and Without Atrial Fibrillation.
Rizzi SA, Knight S, May HT, Woller SC, Stevens SM, Steinberg BA, Bair TL, Anderson JL, Muhlestein JB, Knowlton KU, Bunch TJ. Rizzi SA, et al. Among authors: woller sc. Am J Cardiol. 2021 Aug 15;153:58-64. doi: 10.1016/j.amjcard.2021.05.021. Epub 2021 Jun 25. Am J Cardiol. 2021. PMID: 34176597
The purposes of this study were to examine the impact of depression on TTR and to describe the partitioned contribution of depression and TTR on long-term dementia risk. We studied 14,953 patients anticoagulated with warfarin (target INR 2-3) for atrial fibrillation (AF), …
The purposes of this study were to examine the impact of depression on TTR and to describe the partitioned contribution of depression and TT …
Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study.
Bunch TJ, Jacobs V, May H, Stevens SM, Crandall B, Cutler M, Day JD, Mallender C, Olson J, Osborn J, Weiss JP, Woller SC. Bunch TJ, et al. Among authors: woller sc. Clin Cardiol. 2019 May;42(5):506-512. doi: 10.1002/clc.23181. Epub 2019 Apr 10. Clin Cardiol. 2019. PMID: 30937935 Free PMC article.
Observational trials suggest that the implementation and quality of long-term anticoagulation impact dementia risk. Emerging evidence suggests that direct oral anticoagulants may improve long-term risk of dementia in AF patients. ...CAF investigates if AF patients r …
Observational trials suggest that the implementation and quality of long-term anticoagulation impact dementia risk. Emerging evidence …
Atrial fibrillation incrementally increases dementia risk across all CHADS(2) and CHA(2)DS(2)VASc strata in patients receiving long-term warfarin.
Graves KG, May HT, Jacobs V, Bair TL, Stevens SM, Woller SC, Crandall BG, Cutler MJ, Day JD, Mallender C, Osborn JS, Peter Weiss J, Jared Bunch T. Graves KG, et al. Among authors: woller sc. Am Heart J. 2017 Jun;188:93-98. doi: 10.1016/j.ahj.2017.02.026. Epub 2017 Feb 24. Am Heart J. 2017. PMID: 28577686
After multivariable adjustment, AF patients continued to display a significantly increased risk of dementia when compared with non-AF patients across all CHADS(2) scores strata. CONCLUSIONS: In patients receiving long-term warfarin therapy, dementia risk increased with inc …
After multivariable adjustment, AF patients continued to display a significantly increased risk of dementia when compared with non-AF patien …
The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.
Golive A, May HT, Bair TL, Jacobs V, Crandall BG, Cutler MJ, Day JD, Mallender C, Osborn JS, Stevens SM, Weiss JP, Woller SC, Bunch TJ. Golive A, et al. Among authors: woller sc. Am J Cardiol. 2017 Jul 1;120(1):75-82. doi: 10.1016/j.amjcard.2017.03.256. Epub 2017 Apr 12. Am J Cardiol. 2017. PMID: 28483209
Without randomized, prospective data, the need and type of long-term antithrombotic medications for thromboembolism prevention in lower risk AF patients remains controversial. We sought to define the long-term impact of anticoagulant and antiplatelet therapy use in …
Without randomized, prospective data, the need and type of long-term antithrombotic medications for thromboembolism prevention in low …
Atrial Fibrillation Patients Treated With Long-Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long-Term Warfarin for Other Indications.
Bunch TJ, May HT, Bair TL, Crandall BG, Cutler MJ, Day JD, Jacobs V, Mallender C, Osborn JS, Stevens SM, Weiss JP, Woller SC. Bunch TJ, et al. Among authors: woller sc. J Am Heart Assoc. 2016 Jul 11;5(7):e003932. doi: 10.1161/JAHA.116.003932. J Am Heart Assoc. 2016. PMID: 27402230 Free PMC article.
The purpose of this study was to determine the extent to which AF itself increases dementia risk, in addition to long-term anticoagulation exposure. METHODS AND RESULTS: A total of 10 537 patients anticoagulated with warfarin (target INR 2-3), managed by the Clinical Pharm …
The purpose of this study was to determine the extent to which AF itself increases dementia risk, in addition to long-term anticoagul …
Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
Jacobs V, May HT, Bair TL, Crandall BG, Cutler MJ, Day JD, Mallender C, Osborn JS, Stevens SM, Weiss JP, Woller SC, Bunch TJ. Jacobs V, et al. Among authors: woller sc. Am J Cardiol. 2016 Jul 15;118(2):210-4. doi: 10.1016/j.amjcard.2016.04.039. Epub 2016 May 5. Am J Cardiol. 2016. PMID: 27236255
Patients receiving long-term anticoagulation from June 2010 to December 2014 for thromboembolism prevention with either warfarin or a DOAC were matched 1:1 by index date and propensity score. ...Average age was 72.4 10.9 years, and 59.0% were men. Most patients were receiv …
Patients receiving long-term anticoagulation from June 2010 to December 2014 for thromboembolism prevention with either warfarin or a …
Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.
Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L. Kearon C, et al. Among authors: woller sc. Chest. 2016 Feb;149(2):315-352. doi: 10.1016/j.chest.2015.11.026. Epub 2016 Jan 7. Chest. 2016. PMID: 26867832
METHODS: We generate strong (Grade 1) and weak (Grade 2) recommendations based on high- (Grade A), moderate- (Grade B), and low- (Grade C) quality evidence. RESULTS: For VTE and no cancer, as long-term anticoagulant therapy, we suggest dabigatran (Grade 2B), rivaroxaban (G …
METHODS: We generate strong (Grade 1) and weak (Grade 2) recommendations based on high- (Grade A), moderate- (Grade B), and low- (Grade C) q …
14 results